Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA NABPLAGEM in Untreated Metastatic Pancreatic Cancer
NCT03797443Phase 2Withdrawn
- Sponsor
- Piedmont Cancer Institute
- Start
- Jan 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid, sponsored by Piedmont Cancer Institute. Planned start Jan 2019; status: withdrawn.
02
Drugs
ascorbic acid
Beyond the preview
Go deeper on NCT03797443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03797443.